vai direttamente al contenuto - go to content

Questo sito è accessibile da tutti i browser e gli user agent, ma il design e alcune funzionalità minori dell'interfaccia saranno visibili solo con i browser che rispettano gli standard definiti dal W3C

IFOM Publications 2008

More to explore
  1. AAntoniou AC, Spurdle AB, Sinilnikova OM, Healey S, Pooley KA, Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Hofmann W, Sutter C, Niederacher D, Deissler H, Caldes T, Kämpjärvi K, Nevanlinna H, Simard J, Beesley J, Chen X; Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Neuhausen SL, Rebbeck TR, Wagner T, Lynch HT, Isaacs C, Weitzel J, Ganz PA, Daly MB, Tomlinson G, Olopade OI, Blum JL, Couch FJ, Peterlongo P, Manoukian S, Barile M, Radice P, Szabo CI, Pereira LH, Greene MH, Rennert G, Lejbkowicz F, Barnett-Griness O, Andrulis IL, Ozcelik H; OCGN, Gerdes AM, Caligo MA, Laitman Y, Kaufman B, Milgrom R, Friedman E; Swedish BRCA1 and BRCA2 study collaborators, Domchek SM, Nathanson KL, Osorio A, Llort G, Milne RL, Benítez J, Hamann U, Hogervorst FB, Manders P, Ligtenberg MJ, van den Ouweland AM; DNA-HEBON collaborators, Peock S, Cook M, Platte R, Evans DG, Eeles R, Pichert G, Chu C, Eccles D, Davidson R, Douglas F; EMBRACE, Godwin AK, Barjhoux L, Mazoyer S, Sobol H, Bourdon V, Eisinger F, Chompret A, Capoulade C, Bressac-de Paillerets B, Lenoir GM, Gauthier-Villars M, Houdayer C, Stoppa-Lyonnet D; GEMO, Chenevix-Trench G, Easton DF; CIMBA.
    Common Breast Cancer-Predisposition Alleles Are Associated with Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
    Am J Hum Genet. 2008, Apr;82(4); 937-48. IF: 11,092
  2. Marroni F, Cipollini G, Peissel B, D'Andrea E, Pensabene M, Radice P, Caligo MA, Presciuttini S, Bevilacqua G.
    Reconstructing the Genealogy of a BRCA1 Founder Mutation by Phylogenetic Analysis.
    Ann Hum Genet. 2008, May, 72(Pt 3); 310-8. IF: 2,307
  3. Sahores M, Prinetti A, Chiabrando G, Blasi F, Sonnino S.
    uPA binding increases UPAR localization to lipid rafts and modifies the receptor microdomain composition.
    Biochim Biophys Acta. 2008, Jan;1778(1); 250-259. NO IF
  4. Ami D, Neri T, Natalello A, Mereghetti P, Doglia SM, Zanoni M, Zuccotti M, Garagna S, Redi CA.
    Embryonic stem cell differentiation studied by FT-IR spectroscopy.
    Biochim Biophys Acta, 2008, Jan;1783(1); 98-106. NO IF
  5. Cesaroni M, Cittaro D, Brozzi A, Pelicci PG, Luzi L.
    CARPET: a web-based package for the analysis of ChIP-chip and expression tiling data.
    Bioinformatics. 2008, Dec 15;24(24); 2918-20 . IF: 5,039
  6. Cermenati S, Moleri S, Cimbro S, Corti P, Del Giacco L, Amodeo R, Dejana E, Koopman P, Cotelli F, Beltrame M.
    Sox18 and Sox7 play redundant roles in vascular development.
    Blood. 2008, Mar 1;111(5); 2657-66. IF: 10,896
  7. Birdsey GM, Dryden NH, Amsellem V, Gebhardt F, Sahnan K, Haskard DO, Dejana E, Mason JC, Randi AM.
    Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin.
    Blood. 2008, Apr 1;111(7); 3498-506. IF: 10,896
  8. Alfano M, Mariani SA, Elia C, Pardi R, Blasi F, Poli G.
    Ligand-engaged urokinase-type plasminogen activator receptor (uPAR) and activation of the CD11b/CD18 (Mac1) integrin inhibit late events of HIV expression in monocytic cells.
    Blood. Epub 2008 Oct 21. IF: 10,896
  9. Mosca R, Brannetti B, Schneider TR.
    Alignment of protein structures in the presence of domain motions.
    BMC Bioinformatics. 2008, Aug 27;9; 352. IF: 3,493
  10. Loi S, Haibe-Kains B, Desmedt C, Wirapati P, Lallemand F, Tutt AM, Gillet C, Ellis P, Ryder K, Reid JF, Daidone MG, Pierotti MA, Berns EM, Jansen MP, Foekens JA, Delorenzi M, Bontempi G, Piccart MJ, Sotiriou C.
    Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen.
    BMC Genomics. 2008, May 22;9; 239. IF: 4,180
  11. De Vecchi G, Verderio P, Pizzamiglio S, Manoukian S, Barile M, Fortuzzi S, Ravagnani F, Pierotti MA, Radice P, Peterlongo P.
    Evidences for association of the CASP8 -652 6N del promoter polymorphism with age at diagnosis in familial breast cancer cases.
    Breast Cancer Res Treat. 2009 Feb;113(3); 607-8 (Epub 2008 Mar 16). IF: 4,453
  12. Antoniou AC, Cunningham AP, Peto J, Evans DG, Lalloo F, Narod SA, Risch HA, Eyfjord JE, Hopper JL, Southey MC, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tryggvadottir L, Syrjakoski K, Kallioniemi OP, Eerola H, Nevanlinna H, Pharoah PD, Easton DF.
    The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.
    Br J Cancer. 2008, Apr 22;98(8);1457-66. IF: 4,365
  13. Osorio A, Pollán M, Pita G, Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Preisler-Adams S, Niederacher D, Hofmann W, Gadzicki D, Jakubowska A, Hamann U, Lubinski J, Toloczko-Grabarek A, Cybulski C, Debniak T, Llort G, Yannoukakos D, Díez O, Peissel B, Peterlongo P, Radice P, Heikkinen T, Nevanlinna H, Mai PL, Loud JT, McGuffog L, Antoniou AC, Benitez J.
    An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriers.
    Br J Cancer. 2008, Sep 16;99(6); 974-7. IF: 4,365
  14. Liedtke C, Cardone L, Tordai A, Yan K, Gomez HL, Figureoa LJ, Hubbard RE, Valero V, Souchon EA, Symmans WF, Hortobagyi GN, Bardelli A, Pusztai L
    PIK3CA-activating mutations and chemotherapy sensitivity in stage II-III breast cancer.
    Breast Cancer Res. 2008, 10(2); R27. IF: 4,371
  15. De Vecchi G, Verderio P, Pizzamiglio S, Manoukian S, Bernard L, Pensotti V, Volorio S, Ravagnani F, Radice P, Peterlongo P.
    The p53 Arg72Pro and Ins16bp polymorphisms and their haplotypes are not associated with breast cancer risk in BRCA-mutation negative familial cases.
    Cancer Detect Prev. 2008, 32(2); 140-3 . IF: 1,600
  16. Tapinassi C, Gerbino E, Malazzi O, Micucci C, Gasparini P, Najera MJ, Calasanz MJ, Odero MD, Pelicci PG, Belloni E.
    A new dic(7;12)(p12.21;p12.2) chromosome aberration in a case of acute myeloid leukemia.
    Cancer Genet Cytogenet. 2008, Sep;185(2); 102-5. IF: 1,559
  17. Fernandez LC, Errico MC, Bottero L, Penkov D, Resnati M, Blasi F, Caré A.
    Oncogenic HoxB7 requires TALE cofactors and is inactivated by a dominant-negative Pbx1 mutant in a cell-specific manner.
    Cancer Lett. 2008, Aug 8;266(2); 44-55. IF: 3,398
  18. Frattini M, Gallino G, Signoroni S, Balestra D, Lusa L, Battaglia L, Sozzi G, Bertario L, Leo E, Pilotti S, Pierotti MA.
    Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer.
    Cancer Lett. 2008, May 18;263 (2); 70-81. IF: 3,398
  19. Zecchini S., Bianchi M., Colombo N., Fasani R., Goisis, G., Casadio C., Viale G., Liu J., Herlyn M., Godwin A.K., Nuciforo P., and Cavallaro U.
    The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium.
    Cancer Res. 2008, Feb 15;68(4); 1110-8. IF: 7,672
  20. Ciferri C, Pasqualato S, Screpanti E, Varetti G, Santaguida S, Dos Reis G, Maiolica A, Polka J, De Luca JG, De Wulf P, Salek M, Rappsilber J, Moores CA, Salmon ED, Musacchio A.
    Implications for kinetochore-microtubule attachment from the structure of an engineered Ndc80 complex.
    Cell. 2008, May 2;133(3); 427-39. IF: 29,887
  21. Palamidessi A, Frittoli E, Garré M, Faretta M, Mione M, Testa I, Diaspro A, Lanzetti L, Scita G, Di Fiore PP.
    Endocytic trafficking of rac is required for the spatial restriction of signaling in cell migration.
    Cell. 2008, Jul 11;134(1); 135-47. IF: 29,887
  22. Acosta JC, O'Loghlen A, Banito A, Guijarro MV, Augert A, Raguz S, Fumagalli M, Da Costa M, Brown C, Popov N, Takatsu Y, Melamed J, d'Adda di Fagagna F, Bernard D, Hernando E, Gil J.
    Chemokine signaling via the CXCR2 receptor reinforces senescence.
    Cell. 2008, Jun 13;133(6); 1006-18. IF: 29,887
  23. Polo S, Di Fiore PP.
    Finding the Right Partner: Science or ART?
    Cell. 2008, Nov 14;135(4); 590-2. IF: 29,887
  24. Bianchi F, Nicassio F, Di Fiore PP.
    Unbiased vs. biased approaches to the identification of cancer signatures: the case of lung cancer.
    Cell Cycle. 2008, Jan 14;7(6). IF: 3,314
  25. Arena S, Bardelli A.
    Understanding how kinase-targeted therapies work.
    Cell Cycle. 2008, Jun;7(11); 1560-3. IF: 3,314
  26. Fiorani S, Mimun G, Caleca L, Piccini D, Pellicioli A.
    Characterization of the activation domain of the Rad53 checkpoint kinase.
    Cell Cycle. 2008, Feb 15;7(4); 493-9. IF: 3,314
  27. Di Micco R, Cicalese A, Fumagalli M, Dobreva M, Verrecchia A, Pelicci PG, di Fagagna FD.
    DNA damage response activation in mouse embryonic fibroblasts undergoing replicative senescence and following spontaneous immortalization.
    Cell Cycle. 2008, 8;7(22). IF: 3,314
  28. Vissers JH, Nicassio F, van Lohuizen M, Di Fiore PP, Citterio E.
    The many faces of ubiquitinated histone H2A: insights from the DUBs.
    Cell Div. 2008, Apr 22;3(1):8. NO IF
  29. Zovein AC, Hofmann JJ, Lynch M, French WJ, Turlo KA, Yang Y, Becker MS, Zanetta L, Dejana E, Gasson JC, Tallquist MD, Iruela-Arispe ML.
    Fate tracing reveals the endothelial origin of hematopoietic stem cells.

    Cell Stem Cell. 2008, Dec 4;3(6); 625-36. NO IF
  30. Mezzanzanica D, Fabbi M, Bagnoli M, Staurengo S, Losa M, Balladore E, Alberti P, Lusa L, Ditto A, Ferrini S, Pierotti MA, Barbareschi M, Pilotti S, Canevari S.
    Subcellular Localization of Activated Leukocyte Cell Adhesion Molecule Is a Molecular Predictor of Survival in Ovarian Carcinoma Patients.
    Clin Cancer Res. 2008, Mar 15;14(6); 1726-1733. IF: 6,250
  31. Rudini N, Dejana E.
    Adherens junctions.
    Curr Biol. 2008, Dec 9;18(23); R1080-2. IF: 10,539
  32. Disanza A, Scita G.
    Cytoskeletal regulation: coordinating actin and microtubule dynamics in membrane trafficking.
    Curr Biol. 2008, Sep 23;18(18); R873-5. IF: 10,539
  33. Pocock R, Mione M, Hussain S, Maxwell S, Pontecorvi M, Aslam S, Gerrelli D, Sowden JC, Woollard A.
    Neuronal function of Tbx20 conserved from nematodes to vertebrates.
    Dev Biol. 2008, May 15;317(2); 671-85. IF: 4,714
  34. Combes AN, Wilhelm D, Davidson T, Dejana E, Harley V, Sinclair A, Koopman P.
    Endothelial cell migration directs testis cord formation.
    Dev Biol. 2009, Feb 1;326(1); 112-120 (Epub 2008 Nov 7.) IF: 4,714
  35. Sigismund S, Argenzio E, Tosoni D, Cavallaro E, Polo S, Di Fiore PP.
    Clathrin-mediated internalization is essential for sustained EGFR signaling but dispensable for degradation.
    Dev Cell. 2008, Aug;15(2); 209-19. IF:12,436
  36. Mione M, Baldessari D, Deflorian G, Nappo G, Santoriello C
    How neuronal migration contributes to the morphogenesis of the CNS: insights from the zebrafish.
    Dev Neurosci. 2008, 30(1-3); 65-81. NO IF
  37. Gore AV, Lampugnani MG, Dye L, Dejana E, Weinstein BM.
    Combinatorial interaction between CCM pathway genes precipitates hemorrhagic stroke.
    Dis Model Mech. 2008, Nov;1(4-5); 275-81. NO IF
  38. Muzzini DM, Plevani P, Boulton SJ, Cassata G, Marini F.
    Caenorhabditis elegans POLQ-1 and HEL-308 function in two distinct DNA interstrand cross-link repair pathways.
    DNA Repair (Amst). 2008, Jun 1;7(6); 941-50. IF: 4,018
  39. Ohuchi T, Seki M, Branzei D, Maeda D, Ui A, Ogiwara H, Tada S, Enomoto T.
    Rad52 sumoylation and its involvement in the efficient induction of homologous recombination.
    DNA Repair (Amst). 2008, Jun 1;7(6); 879-89. IF: 4,018
  40. Rudini N, Felici A, Giampietro C, Lampugnani M, Corada M, Swirsding K, Garrè M, Liebner S, Letarte M, Ten Dijke P, Dejana E.
    VE-cadherin is a critical endothelial regulator of TGF-beta signalling.
    EMBO J. 2008, Apr 9;27(7); 993-1004. IF: 8,662
  41. Nyqvist D, Giampietro C, Dejana E.
    Deciphering the functional role of endothelial junctions by using in vivo models.
    EMBO Rep. 2008, Aug;9(8); 742-7. IF: 7,450
  42. Cappelletti V, Gariboldi M, De Cecco L, Toffanin S, Reid JF, Lusa L, Bajetta E, Celio L, Greco M, Fabbri A, Pierotti MA, Daidone MG.
    Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer.
    Endocr Relat Cancer. 2008, Jun;15(2); 439-449. IF: 5,193
  43. Martin-Padura I, de Nigris F, Migliaccio E, Mansueto G, Minardi S, Rienzo M, Lerman LO, Stendardo M, Giorgio M, De Rosa G, Pelicci PG, Napoli C.
    p66(Shc) Deletion Confers Vascular Protection in Advanced Atherosclerosis in Hypercholesterolemic Apolipoprotein E Knockout Mice.
    Endothelium. 2008, Sep-Oct;15(5); 276-87. IF: 1,74
  44. Testa I, Garrè M, Parazzoli D, Barozzi S, Ponzanelli I, Mazza D, Faretta M, Diaspro A.
    Photoactivation of pa-GFP in 3D: optical tools for spatial confinement.
    Eur Biophys J. 2008, Apr;230(Pt 1); 48-60. IF: 2,238
  45. Tavecchio M, Simone M, Erba E, Chiolo I, Liberi G, Foiani M, D'Incalci M, Damia G.
    Role of homologous recombination in trabectedin-induced DNA damage.
    Eur J Cancer. 2008, Mar;44(4); 609-18. IF: 4,454
  46. Madsen CD, Sidenius N.
    The interaction between urokinase receptor and vitronectin in cell adhesion and signaling
    Eur J Cell Biol. 2008, Sep;87(8-9); 617-29. IF: 3,224
  47. d'Adda di Fagagna F.
    Cellular senescence and cellular longevity: nearly 50 years on and still working on it.
    Experimental Cell research. 2008, Jun 10;314(9); 1907-8. IF: 3,695
  48. Tosoni D, Cestra G.
    CAP (Cbl associated protein) regulates receptor-mediated endocytosis.
    FEBS Lett. 2009, Jan 22;583(2); 293-300 (Epub 2008 Dec 29). IF: 3,263
  49. Vetrano S, Rescigno M, Cera MR, Correale C, Rumio C, Doni A, Fantini M, Sturm A, Borroni E, Repici A, Locati M, Malesci A, Dejana E, Danese S.
    Unique Role of Junctional Adhesion Molecule-A in Maintaining Mucosal Homeostasis in Inflammatory Bowel Disease.
    Gastroenterology. 2008, Jul;135(1); 173-84. IF: 11,673
  50. Bermejo R, Branzei D, Foiani M.
    Cohesion by topology: sister chromatids interlocked by DNA.
    Genes Dev. 2008, Sep 1;22(17); 2297-301. IF: 14,795
  51. Settembre C, Fraldi A, Jahreiss L, Spampanato C, Venturi C, Medina D, Pablo RD, Tacchetti C, Rubinsztein DC, Ballabio A.
    A Block of Autophagy in Lysosomal Storage Disorders.
    Hum Mol Genet. 2008, Jan 1;17(1); 119-29. IF: 7,806
  52. Benvenuti S, Frattini M, Arena S, Zanon C, Cappelletti V, Coradini D, Daidone MG, Pilotti S, Pierotti MA, Bardelli A.
    PIK3CA cancer mutations display gender and tissue specificity patterns.
    Hum Mutat. 2008, Feb;29(2); 284-8. IF: 6,273
  53. Spurdle AB, Couch FJ, Hogervorst FB, Radice P, Sinilnikova OM; IARC Unclassified Genetic Variants Working Group.
    Prediction and assessment of splicing alterations: implications for clinical testing
    Hum Mutat. 2008, Nov;29(11); 1304-13. IF: 6,273
  54. Bleeker FE, Lamba S, Rodolfo M, Scarpa A, Leenstra S, Vandertop WP, Bardelli A.
    Mutational profiling of cancer candidate genes in glioblastoma, melanoma and pancreatic carcinoma reveals a snapshot of their genomic landscapes.
    Hum Mutat. 2009, Feb;30(2); E451-9.( Epub 2008 Dec 4.) IF: 6,273
  55. Hao Z, Duncan GS, Seagal J, Su YW, Hong C, Haight J, Chen NJ, Elia A, Wakeham A, Li WY, Liepa J, Wood GA, Casola S, Rajewsky K, Mak TW.
    Fas Receptor Expression in Germinal-Center B Cells Is Essential for T and B Lymphocyte Homeostasis.
    Immunity. 2008, Oct;29(4); 615-27. IF: 19,266
  56. Pelizzoli R, Tacchetti C, Luzzi P, Strangio A, Bellese G, Zappia E, Guazzi S.
    TTF-1/NKX2.1 up-regulates the in vivo transcription of nestin.
    Int J Dev Biol. 2008, 52(1); 55-62. IF: 2,830
  57. Toffanin S, Daidone MG, Miodini P, De Cecco L, Gandellini P, Cappelletti V.
    Clusterin: A potential target for improving response to antiestrogens.
    Int J Oncol. 2008, Oct;33(4); 791-8. IF: 2,295
  58. Malengo G, Andolfo A, Sidenius N, Gratton E, Zamai M, Caiolfa VR.
    Fluorescence correlation spectroscopy and photon counting histogram on membrane proteins: functional dynamics of the glycosylphosphatidylinositol-anchored urokinase plasminogen activator receptor.
    J Biomed Opt. 2008, May-Jun;13(3); 31215. IF: 3,084
  59. Bianchini P, Calzia D, Ravera S, Candiano G, Bachi A, Morelli A, Bruschi M, Pepe IM, Diaspro A, Panfoli I.
    Live imaging of mammalian retina: rod outer segments are stained by conventional mitochondrial dyes.
    J Biomed Opt. 2008, Sep-Oct;13(5). IF: 3,084
  60. Di Fiore PP
    Playing both sides: nucleophosmin between tumor suppression and oncogenesis.
    J Cell Biol. 2008, Jul 14;182(1); 7-9. IF: 9,598
  61. Liebner S, Corada M, Bangsow T, Babbage J, Taddei A, Czupalla CJ, Reis M, Felici A, Wolburg H, Fruttiger M, Taketo MM, von Melchner H, Plate KH, Gerhardt H, Dejana E.
    Wnt/beta-catenin signaling controls development of the blood-brain barrier.
    J Cell Biol. 2008, Nov 3;183(3); 409-17. IF: 9,598
  62. Turowski P, Martinelli R, Crawford R, Wateridge D, Papageorgiou AP, Lampugnani MG, Gamp AC, Vestweber D, Adamson P, Dejana E, Greenwood J.
    Phosphorylation of vascular endothelial cadherin controls lymphocyte emigration.
    J Cell Sci. 2008, Jan 1;1211(Pt 1); 29-37. IF: 6,383
  63. Dejana E, Orsenigo F, Lampugnani MG.
    The role of adherens junctions and VE-cadherin in the control of vascular permeability.
    J Cell Sci. 2008, Jul 1;121(Pt 13); 2115-22. IF: 6,383
  64. D'Alessio S, Gerasi L, Blasi F.
    uPAR-deficient mouse keratinocytes fail to produce EGFR-dependent laminin-5, affecting migration in vivo and in vitro.
    J Cell Sci. 2008, Dec 1;121(Pt 23); 3922-32. IF: 6,383
  65. Malacrida S, Agata S, Callegaro M, Casella C, Barana D, Scaini MC, Manoukian S, Oliani C, Radice P, Barile M, Menin C, D'Andrea E, Montagna M.
    BRCA1 p.Val1688del is a deleterious mutation that recurs in breast and ovarian cancer families from Northeast Italy.
    J Clin Oncol. 2008, Jan 1;26(1); 26-31. IF: 15,484
  66. Di Nicolantonio F, Martini M, Molinari F, Sartore-Bianchi A, Arena S, Saletti P, De Dosso S, Mazzucchelli L, Frattini M, Siena S, Bardelli A.
    Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.
    J Clin Oncol. 2008, Dec 10;26(35); 5705-12. IF: 15,484
  67. Gregori D, Lusa L, Rosato R, Silvestri L.
    Evaluating effectiveness of preoperative testing procedure: some notes on modelling strategies in multi-centre surveys.
    J Eval Clin Pract. 2008, Feb;14(1); 11-8. IF: 1,570
  68. Hömig-Hölzel C, Hojer C, Rastelli J, Casola S, Strobl LJ, Müller W, Quintanilla-Martinez L, Gewies A, Ruland J, Rajewsky K, Zimber-Strobl U.
    Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-kappaB pathway and promotes lymphomagenesis.
    J Exp Med. 2008, Jun 9;205(6); 1317-29. IF: 15,612
  69. Camporesi S, Boniolo G.
    Fearing a non-existing Minotaur? The ethical challenges of research on cytoplasmic hybrid embryos.
    J Med Ethics, 2008 Nov;34(11); 821-5. IF:1,103
  70. Testa I, Parazzoli D, Barozzi S, Garrè M, Faretta M, Diaspro A.
    Spatial control of pa-GFP photoactivation in living cells.
    J Microsc. 2008, Apr;230(Pt 1); 48-60. NO IF.
  71. Lusa L, Peissel B, Manoukian S, Marchesi E, Radice P, Pierotti MA, Gariboldi M.
    Re: Molecular Basis for Estrogen Receptor {alpha} Deficiency in BRCA1-Linked Breast Cancer.
    J Natl Cancer Inst. 2008, May 21;100(10); 752-3. IF: 15,678
  72. Nebuloni M, Cinque P, Sidenius N, Ferri A, Lauri E, Omodeo-Zorini E, Zerbi P, Vago L.
    Expression of the urokinase plasminogen activator receptor (uPAR) and its ligand (uPA) in brain tissues of human immunodeficiency virus patients with opportunistic cerebral diseases.
    J Neurovirol. 2008, Dec 29; 1-9. IF: 1.943
  73. Panfoli I, Musante L, Bachi A, Ravera S, Calzia D, Cattaneo A, Bruschi M, Bianchini P, Diaspro A, Morelli A, Pepe IM, Tacchetti C, Candiano G.
    Proteomic Analysis of the Retinal Rod Outer Segment Disks.
    J Proteome Res. 2008, Jul;7(7); 2654-69. IF: 5,675
  74. Sabouri-Ghomi M, Ciliberto A, Kar S, Novak B, Tyson JJ.
    Antagonism and bistability in protein interaction networks.
    J Theor Biol. 2008, Jan 7;250(1); 209-18. IF: 2,323
  75. Ferrario C, Lavagni P, Gariboldi M, Miranda C, Losa M, Cleris L, Formelli F, Pilotti S, Pierotti MA, Greco A.
    Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinoma.
    Lab Invest. 2008, May; 88(5); 474-81. IF: 4,479
  76. Galaup A, Germain S.
    Blocking PlGF, a future in anti-angiogenic therapy?
    Med Sci (Paris). 2008, May;24(5); 459-462. NO IF
  77. Vintersten K, Testa G, Naumann R, Anastassiadis K, Stewart AF.
    Bacterial artificial chromosome transgenesis through pronuclear injection of fertilized mouse oocytes.
    Methods Mol Biol. 2008, 415:83; 100. NO IF
  78. Gallus L, Ferrando S, Bottaro M, Diaspro A, Girosi L, Faimali M, Ramoino P, Tagliafierro G.
    Presence and distribution of FMRFamide-like immunoreactivity in the cyprid of the barnacle Balanus amphitrite (Cirripedia, crustacea).
    Microsc Res Tech. 2008, Oct 20;72(2); 101-109. IF: 1,644
  79. Colombo M, Giarola M, Mariani L, Ripamonti CB, De Benedetti V, Sardella M, Losa M, Manoukian S, Peissel B, Pierotti MA, Pilotti S, Radice P.
    Cyclin D1 expression analysis in familial breast cancers may discriminate BRCAX from BRCA2-linked cases.
    Mod Pathol. 2008, Oct;21(10); 1262-70. IF: 4,286
  80. Frittoli E, Palamidessi A, Pizzigoni A, Lanzetti L, Garrè M, Troglio F, Troilo A, Fukuda M, Di Fiore PP, Scita G, Confalonieri S.
    The Primate-specific Protein TBC1D3 is Required for Optimal Macropinocytosis in a Novel ARF6 Dependent Pathway.
    Mol Biol Cell. 2008, Apr;19(4); 1304-1316. IF: 6,028
  81. Oriente F, Fernandez Diaz LC, Miele C, Iovino S, Mori S, Diaz VE, Troncone G, Cassese A, Formisano P, Blasi F, Beguinot F.
    Prep1 deficiency induces protection from diabetes and increased insulin sensitivity through a p160-mediated mechanism.
    Mol Cell Biol. 2008, Sep;28(18); 5634-45. IF: 6,420
  82. Micali N, Ferrai C, Fernandez-Diaz LC, Blasi F, Crippa MP.
    Prep1 directly regulates the intrinsic apoptotic pathway by controlling Bcl-XL levels.
    Mol Cell Biol Epub 2008 Dec 22. IF: 6,420
  83. Carvalho M, Pino MA, Karchin R, Beddor J, Godinho-Netto M, Mesquita RD, Rodarte RS, Vaz DC, Monteiro VA, Manoukian S, Colombo M, Ripamonti CB, Rosenquist R, Suthers G, Borg A, Radice P, Grist SA, Monteiro AN, Billack B.
    Analysis of a set of missense, frameshift, and in-frame deletion variants of BRCA1.
    Mutat Res (FUND MOL M) 2009, Jan 15;660(1-2); 1-11 (Epub 2008 Dec 22.) IF: 4,159
  84. Taddei A, Giampietro C, Conti A, Orsenigo F, Breviario F, Pirazzoli V, Potente M, Daly C, Dimmeler S, Dejana E.
    Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5.
    Nat Cell Biol. 2008, Aug;10(8); 923-34. IF: 17,623
  85. Branzei D, Foiani M.
    Regulation of DNA repair throughout the cell cycle.
    Nat Rev Mol Cell Biol. 2008, Apr;9(4); 297-308. IF: 31,921
  86. Colaluca IN, Tosoni D, Nuciforo P, Senic-Matuglia F, Galimberti V, Viale G, Pece S, Di Fiore PP.
    NUMB controls p53 tumour suppressor activity.
    Nature. 2008, Jan 3;451(7174); 76-80. IF: 28,751
  87. François M, Caprini A, Hosking B, Orsenigo F, Wilhelm D, Browne C, Paavonen K, Karnezis T, Shayan R, Downes M, Davidson T, Tutt D, Cheah KS, Stacker SA, Muscat GE, Achen MG, Dejana E, Koopman P.
    Sox18 induces development of the lymphatic vasculature in mice.
    Nature. 2008, Dec 4;456(7222); 643-7. IF: 28,751
  88. Branzei D, Vanoli F, Foiani M.
    SUMOylation regulates Rad18-mediated template switch.
    Nature. 2008, Dec 18;456(7224); 915-20. IF: 28,751
  89. d'Adda di Fagagna F.
    Living on a break: cellular senescence as a DNA damage response.
    Nature Reviews Cancer. 2008, Jul;8(7); 512-22. IF: 29,190
  90. Zecchini S, Cavallaro U.
    Neural Cell Adhesion Molecule in Cancer: Expression and Mechanisms.
    Neurochem Res (Epub 2008 Mar 6) IF: 1,811
  91. Mosca R, Schneider TR.
    RAPIDO: a web server for the alignment of protein structures in the presence of conformational changes.
    Nucleic Acids Res. 2008, Jul 1;36 (Web Server issue). IF: 6,954
  92. Perotti D, Gamba B, Sardella M, Spreafico F, Terenziani M, Collini P, Pession A, Nantron M, Fossati-Bellani F, Radice P.
    Functional inactivation of the WTX gene is not a frequent event in Wilms' tumors.
    Oncogene. 2008, Jul 31;27(33); 4625-32. IF: 6,440
  93. Vecchi M, Confalonieri S, Nuciforo P, Vigano MA, Capra M, Bianchi M, Nicosia D, Bianchi F, Galimberti V, Viale G, Palermo G, Riccardi A, Campanini R, Daidone MG, Pierotti MA, Pece S, Di Fiore PP.
    Breast cancer metastases are molecularly distinct from their primary tumors.
    Oncogene. 2008, Apr 3;27(15); 2148-58. IF: 6,440
  94. Bleeker FE, Felicioni L, Buttitta F, Lamba S, Cardone L, Rodolfo M, Scarpa A, Leenstra S, Frattini M, Barbareschi M, Grammastro MD, Sciarrotta MG, Zanon C, Marchetti A, Bardelli A.
    AKT1(E17K) in human solid tumours.
    Oncogene (Epub 2008 May 26) IF: 6,44
  95. Uccini S, Perotti D, Colarossi C, Stoppacciaro A, Sardella M, Mannarino O, Collini P, Casieri P, Cozzi D, Amoroso L, Spreafico F, Radice P, Dominici C.
    Molecular evidence of the independent origin of multiple Wilms tumors in a case of WAGR syndrome.
    Pediatr Blood Cancer. 2008, Sep;51(3); 344-8. IF: 2,164
  96. Alberici P, Gaspar C, Franken P, Gorski MM, de Vries I, Scott RJ, Ristimäki A, Aaltonen LA, Fodde R
    Smad4 haploinsufficiency: a matter of dosage.
    Pathogenetics. 2008, Nov 3;1(1):2. NO IF
  97. Terenziani M, Sardella M, Gamba B, Testi MA, Spreafico F, Ardissino G, Fedeli F, Fossati-Bellani F, Radice P, Perotti D.
    A novel WT1 mutation in a 46,XY boy with congenital bilateral cryptorchidism, nystagmus and Wilms tumor.
    Pediatr Nephrol. (Epub 2008 Dec 2.) IF: 1,375
  98. Baldessari D, Mione M.
    How to create the vascular tree? (Latest) help from the zebrafish.
    Pharmacol Ther. 2008, May;118(2); 206-30. IF: 7,968
  99. Gardini A, Cesaroni M, Luzi L, Okumura AJ, Biggs JR, Minardi SP, Venturini E, Zhang DE, Pelicci PG, Alcalay M.
    AML1/ETO oncoprotein is directed to AML1 binding regions and co-localizes with AML1 and HEB on its targets.
    PLoS Genet. 2008, Nov;4(11); e1000275. IF: 8,721
  100. Penkov D, Palazzolo M, Mondino A, Blasi F.
    Cytosolic sequestration of Prep1 influences early stages of T cell development.
    PLoS ONE. 2008, Jun 18;3(6); e2424. NO IF
  101. Cortese K, Sahores M, Madsen CD, Tacchetti C, Blasi F.
    Clathrin and LRP-1-independent constitutive endocytosis and recycling of uPAR.
    PLoS ONE. 2008, 3(11); e3730. NO IF
  102. Hayashi M, Raimondi A, O'Toole E, Paradise S, Collesi C, Cremona O, Ferguson SM, De Camilli P.
    Cell- and stimulus-dependent heterogeneity of synaptic vesicle endocytic recycling mechanisms revealed by studies of dynamin 1-null neurons.
    Proc Natl Acad Sci U S A. 2008, Feb 12;105(6); 2175-80. IF: 9,598
  103. Di Nicolantonio F, Arena S, Gallicchio M, Zecchin D, Martini M, Flonta SE, Stella GM, Lamba S, Cancelliere C, Russo M, Geuna M, Appendino G, Fantozzi R, Medico E, Bardelli A.
    Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses.
    Proc Natl Acad Sci U S A. 2008, Dec 30;105(52); 20864-9. IF: 9,598
  104. Lorusso L, Boniolo G.
    Clustering humans: on biological boundaries.
    Stud Hist Philos Biol Biomed Sci. 2008, Mar;39(1); 163-70. NO IF
  105. Pia Ragno and Francesco Blasi
    uPAR and proteases in mobilization of hematopoietic stem cells.
    The Cancer Degradome (Wiley) Eds. 2008 P. 433-450. NO IF
  106. Vicidomini G, Gagliani MC, Canfora M, Cortese K, Frosi F, Santangelo C, Di Fiore PP, Boccacci P, Diaspro A, Tacchetti C.
    High Data Output and Automated 3D Correlative Light-Electron Microscopy Method.
    Traffic. 2008, Nov;9(11); 1828-38. IF: 6,533
  107. Lanzetti L, Di Fiore PP.
    Endocytosis and Cancer: an 'Insider' Network with Dangerous Liaisons.
    Traffic (Epub 2008 Aug 14) . IF: 6,533
  108. Scita G, Confalonieri S, Lappalainen P, Suetsugu S.
    RSp53: crossing the road of membrane and actin dynamics in the formation of membrane protrusions.
    Trends Cell Biol. 2008, Feb;18(2) 52-60. IF: 13,527
  109. Rambaldi D, Giorgi FM, Capuani F, Ciliberto A, Ciccarelli FD.
    Low duplicability and network fragility of cancer genes.
    Trends Genet. 2008, Sep;24(9); 427-30. IF: 9,729
  110. Cheng KC; Members of the Zebrafish Community (M.Mione)
    Views on four key questions about zebrafish research.
    Zebrafish. 2008, Spring;5(1); 9-24. NO IF
 
 

IFOM was created and continues to grow
with the help of
logo firc